6/18- Immunization for Prevention of IDs Flashcards

1
Q

History of immunization: broad development of methods?

A
  • Killed viruses -> Protein/CPS -> DNA/rDNA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Vaccine-preventable diseases?

A
  • Smallpox
  • Diphtheria
  • Measles
  • Mumps
  • Pertussis (increase in recent cases…)
  • Polio (paralytic)
  • Rubella
  • Congenital Rubella Syndrome
  • Tetanus
  • Haemophilus influenzae
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

General requirements for immunization (mechanistic)? Mechanism of Protection?

A

General requirements:

  • Activation of APCs, T and B cells with generation of memory (must incorporate B and T-cell epitopes); antigen must persist

Mechanisms of protection

  • Serum and mucosal Abs (prevent and facilitate clearance)
  • Cell mediated immune responses (limit extent of infection and facilitate pathogen clearance)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Properties of an ideal vaccine

A
  • Elicits relevant immune response
  • Confers long-lived immunity
  • Safe and well tolerated
  • Stable and retains potency
  • Affordable
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is passive immunization? Characteristics?

A
  • Administration of Ig-containing material in order to prevent or modify disease
  • Protection conferred immediately
  • Protection generally short-lived
  • Primary use: postexposure prophylaxis, or when vaccine is not available/indicated

(passive immunotherapy involving infusion of Ag-specific cells is being evaluated)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What diseases are treated with passive immunization?

A

Pre-exposure prophylaxis:

  • CMV
  • HAV
  • RSV
  • (ITP, IG deficiency)

Post-exposure prophylaxis:

  • HAV
  • HBV
  • Measles
  • Rabies (with vaccine)
  • Rubella
  • Tetanus
  • VZV

Treatment:

  • Botulism
  • CMV
  • Diphtheria
  • RSV
  • Lassa fever
  • Tetanus
  • Complications of vaccinia
  • ITP
  • Kawasaki disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is active immunization? Characteristics?

A
  • Stimulation of protective immune responses via administration of a vaccine
  • Weeks to months generally are required for responses to develop
  • Protection generally long-lived (may require boosters)
  • Primary use: pre-exposure prophylaxis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Two subsets of active immunization? Characteristics?

A

Non-replicating (inactivated, subunit, conjugate…)

  • Generally safer
  • Generally more stable

Replicating

  • Fewer doses
  • Lower antigen content
  • Broader responses
  • More durable immunity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What factors (vaccine and host) affect immune response to immunization?

A

Vaccine factors:

  • Dosage and route
  • Spacing of doses
  • Type of antigen
  • Adjuvants
  • Combinations

Host factors

  • Age**
  • Immune status
  • Genetic factors
  • Medications
  • Nutritional status
  • Underlying diseases

**Ex) poor response to CPS antigens in infants under 2; overcome by conjugating CPS to protein (T-indep -> T-dep)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

General recommendations for the timing and spacing of immunobiologics (vaccine or antibody…)?

A
  • Observe recommended ages and minimum intervals between doses; generally no need to repeat doses if interval is exceeded
  • Administer recommended vaccines simultaneously unless contraindicated
  • Do not combine vaccines unless safety and immunogenicity have been assessed

Specific recommendations:

  • Antigen combination: minimum interval between doses
  • 2+ inactivated: simultaneous or any interval
  • Inactivated and live: simultaneous or at any interval
  • 2+ live (intranasal or injected)- 4 week interval if not simultaneous*

*Ty21a and rotavirus vaccine can be given together or at any interval before/after other vaccines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

General Recommendations for spacing of Ab-containing products and vaccines?

A
  • In general, antibody-containing products and LIVE vaccines should not be given simultaneously (excluding live typhoid and yellow fever vaccines and LAIV)
  • Antibody-containing products and INACTIVATED vaccines can generally be given simultaneously at different sites
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Examples of serious adverse events associated with biologics? Table of risk of immunizations…

A
  • Diphtheria antitoxin contaminated with tetanus (Biologics Control Act 1902)
  • Incompletely inactivated poliovirus vaccine and vaccine-associated polio (‘the Cutter Incident’)
  • Inactivated measles vaccine: Atypical measles after exposure to wild type virus
  • Inactivated respiratory syncytial virus vaccine: Exaggerated disease/death after exposure to wild type virus
  • Rotavirus vaccine and intussusception
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

True contraindications to immunization?

A
  • Hypersensitivity to component
  • Moderate or severe illness (delay)
  • Encephalopathy within 7 days of immunization with DTP/DTaP
  • OPV: Immunosuppressed & HIV-infected persons and their contacts
  • MMR: Immunodeficient patients
  • Rotavirus: Patients with SCID or history of intussusception
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Immunization not contraindicated when?

A
  • Mild acute illness/convalescence
  • Prior mild/moderate local reaction
  • Antimicrobial therapy
  • Prematurity
  • Recent exposure to infectious agent
  • Nonspecific/penicillin allergies
  • Family history: Allergies, seizures, SIDS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Special considerations for vaccinations?

A
  • Pregnancy
  • Family Hx of immunodeficiency states
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Misconceptions of long term side effects?

A
  • Asthma
  • Attention deficit disorder
  • Autism
  • Chronic fatigue syndrome
  • Diabetes
  • Inflammatory bowel disease
  • Multiple sclerosis
  • SIDS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

T/F: The right of states to pass and enforce compulsory immunization has been confirmed and upheld?

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Exemptions to compulsory immunization include what?

A
  • Medical
  • Religious
  • Philosophical (vary by state)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is contained in the DTaP vaccine? Recommended immunization schedule?

A

Diphtheria-Tetanus-Acellular Pertussis Vaccine

  • Contain up to 5 pertussis components and purified diphtheria and tetanus toxoids (all proteins)
  • Protection correlated with serum Ab (DT); no Ab correlate for pertussis antigens
  • Primary immunization schedule: 5 doses between birth and 6 yrs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Recommendations for use of DTaP vaccine?

  • Indications
  • Contraindications
  • Precautions
A

Indications:

  • Universal immunization of all infants and children up to age 6 years

Contraindications:

  • Encephalopathy within 7 days of receipt of previous dose
  • Progressive neurologic disorder (conditional)

Precautions:

  • High fever, collapse or shock-like state
  • Inconsolable crying >3 hours within 2 days of prior dose
  • Seizure within 3 days of prior dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the Td/Tdap vaccine?

  • Contents
  • Uses
  • Dosage schedule
  • Precautions
A

- Inactivated toxoids (ap contains several pertussis antigens: PT, FHA, PRN, FIM 2&3

Uses:

  • Routine immunization
  • Wound care
  • Adolescent and adult immunization

Schedule:

  • Booster doses of Td or Tdap (once only) recommended for adults every 10 years
  • Tdap during each pregnancy
  • Tdap can be given regardless of interval since last Td for pertussis prevention; replaces next scheduled dose of Td

Precautions:

  • GBS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

DTaP; Tdap summary

  • All infants should _____
  • All adolescents and adults should _____
  • Pregnant women should _____
  • Travelers should _____
A

DTaP; Tdap summary

  • All infants should be immunized with DTaP vaccine (series)
  • All adolescents and adults should receive Tdap vaccine, as should children 7-10 yrs who have not been fully vaccinated
  • Pregnant women should receive Tdap during each pregnancy
  • Travelers should be boosted with Td or Tdap if it has been at least 5 yrs since last booster
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What kind of vaccine is used for H. influenzae?

  • Mechanism
  • Indications
  • Immunization schedule
A

HIB conjugate vaccine

  • Protein-polysaccharide conjugates of the CPS of H. influenzae type B conjugated to one of several proteins: OMP, CRM, or TT
  • Protection mediated by Ab vs. CPS

Indications:

  • Universal immunization of infants Immunization schedule
  • 3-4 doses over 18 months (3 for OMP-CV)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Where is polio endemic?

A
  • Afghanistan
  • Nigeria
  • Pakistan
  • Horn of Africa (type 2 eradicated in 1999)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Characteristics of the poliovirus vaccine? Components/mechanism

A
  • Formalin-inactivated vaccine (IPV)
  • Oral live attenuated vaccine (OPV)

Protection mediated by neutralizing Abs against the 3 serotypes

Because the risk of developing vaccine- associated polio in the U.S. is greater than the risk of infection, routine use of OPV is no longer recommended

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Polio immunization:

  • Indications
  • Contraindications
  • Risk groups
  • Schedule
A

Indications:

  • Universal immunization of infants and children (4 doses) with IPV
  • Not usually recommended for persons over the age of 17 years
  • Consider a 1 time booster dose for adult travelers to endemic areas.

Contraindications:

  • Anaphylactic reactions to streptomycin, neomycin, or polymyxin B Risk groups:
  • Non-immune travelers to Asia and Africa
  • Members of communities or groups with disease caused by wild type polio
  • Lab workers who handle samples containing polio
  • HCW in contact with infected patients; unvaccinated adults in contact with children given

OPV Schedule for unvaccinated adults:

  • 3 doses at least 4 weeks apart (0, 1-2 mo., 6-12 mo. preferable)
  • 2 doses or even 1 dose can be given if time is not available
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What age groups is most affected by measles in the US?

A

> 14 yo

(followed by 0-4 yo)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Outbreak of measles recently where?

A

Measles- Disneyland in CA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What age group is at greater risk for severe disease and death with measles? What should be done?

A

Infants

  • Infants who travel or live abroad should be vaccinated at an earlier age (6-11 mo; dose doesn’t count)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Outbreak of mumps recently where?

A

UT Austin (7 cases)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Principles for mumps control?

A
  • Timely vaccination with 2 doses of MMR vaccine
  • High awareness among HCPs
  • Ongoing surveillance and prompt reporting of mumps cases - Isolation of persons with suspected and confirmed mumps for 5 days after onset of parotitis
  • In congregate settings (colleges, schools): early recognition, diagnosis, and public health intervention
  • During outbreaks: 1 dose of MMR vaccine for adults and children whose vaccination status is unknown or who have not received the number of MMR doses recommended by the ACIP; consideration of a second dose of MMR vaccine for children aged 1 thru 4 years and adults who have received 1 dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Characteristics of MMR vaccine?

  • Components
  • Dosage schedule
  • Contraindications
A
  • Live attenuated virus

Schedule

  • Universal immunization of infants with 2 doses of MMR at 12-15 mo. and 4-6 yrs of age (dose 2 should be given at least 4 wks after dose 1)
  • Children 6-12 months old traveling to endemic areas should receive a dose of vaccine prior to travel; dose doesn’t count (still need 2 doses on or after 12 mo. of age). For others born after 1980: h/o receipt of 2 doses, or verify immunity

- Update: 2 doses recommended for people born after 1956 (in post-high school educational institutions, medical personnel, and those traveling to measles-endemic areas) who lack evidence of immunity: documentation of 2 doses of MMR on/after 1st birthday, measles diagnosis with lab confirmation, lab evidence of immunity

Contraindications:

  • Immune deficiency disorders (OK in HIV infxn if not severely immunocompromised)
  • Anaphylactic reactions to neomycin
  • Pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

HIB, Polio, MMR summary

  • All infants should _______
  • Preferred polio vaccine is ___. Adult travelers should consider ______
  • MMR vaccine: __ doses are recommended for _______ and _____.

Infants traveling to areas where ____ is occurring should be vaccinated at ____ of age.

A

HIB, Polio, MMR summary

  • All infants should be vaccinated with HIB conjugate vaccine
  • Preferred polio vaccine is IPV. Adult travelers should consider a single dose if traveling to areas where polio persists
  • MMR vaccine: 2 doses are recommended for infants and certain adults who only received a single dose.

Infants traveling to areas where measles is occurring should be vaccinated at 6 months of age.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What is this?

A

Left: Varicella

Right: Zoster

35
Q

Characteristics of the Varicella vaccine?

  • Components
  • Schedule
A
  • Live attenuated lyophilized virus (Oka strain)
  • Reconstituted vaccine contains >1,350 PFUs of virus per dose, gelatin, and trace amounts of neomycin

Primary immunization schedule:

  • 2 SQ doses at 12-15 mo and 4-6 yrs or
  • 2 SQ doses at least 4 wks apart

(MMRV can be used for persons 12 mo - 12 yo; assd with increased risk of febrile seizures after 1st dose)

36
Q

Recommendation for use of varicella vaccine?

A
  • Universal immunization of children starting at 12-18 months of age
  • Susceptible older children and adults (consider pre-immunization antibody testing)

Special considerations:

  • Susceptible people who have close contact with those at high risk for complications
  • Women of childbearing age
  • Travelers
  • People who live or work in places where VZV transmission is likely
37
Q

Varicella vaccine: contraindications?

A
  • Congenital or acquired immunodeficiency
  • Pregnancy
  • Allergy to neomycin or gelatin
  • Receipt of ISG within 5 mo (delay)
38
Q

Precautions or special considerations for varicella vaccine?

A
  • Households with immunocompromised contacts
  • Children with ALL in remission
  • Children receiving long-term salicylate therapy: contacts should be immune!
39
Q

T/F: Varicella vaccine can be used for post-exposure prophylaxis?

A

True

  • ACIP recommends vaccine for use in susceptibles following exposure to varicella
  • Can be effective in preventing or modifying illness if used 3-5 days after exposure
40
Q

T/F: Varicella vaccine dramatically reduces occurrence of herpes zoster

A

False; we don’t really know

  • HZ incidence in vaccinated children was 79% lower than unvaccinated children; ~50% were due to wild type virus
41
Q

Characteristics of Shingles vaccine

  • Type
  • Indications
  • Schedule
  • Contraindications
A

Type: live attenuated virus

  • Higher dosage than the varicella vaccine

Indications/Schedule:

  • Single SQ dose recommended for immunocompetent persons > 60 (licensed for > 50 yo)

Contraindications:

  • Hypersensitivity to vaccine components
  • Acquired or iatrogenic immunodeficiency
42
Q

Varicella-Zoster Summary:

  • ____ should be immune to __
  • __ doses of varicella vaccine are recommended for _______
  • ____ can be given to susceptible persons ___ exposure
  • __ dose(s) of shingles vaccine is recommended for ________
A

Varicella-Zoster Summary:

  • Everyone should be immune to VZV
  • 2 doses of varicella vaccine are recommended for non-immune people (unless contraindicated)
  • Varicella vaccine can be given to susceptible persons after exposure
  • A single dose(s) of shingles vaccine is recommended for persons > 60 yo
43
Q

Epidemiology of Rotavirus infections?

A
  • Most important cause of severe diarrhea in infants and children worldwide (Group A)
  • Most primary infections occur during the first 3 years of life
  • Epidemics in temperate climates occur during the cooler months
  • Accounts for 1/3 of hospitalizations for diarrhea and ~ 1/2 million deaths each year
44
Q

Characteristics of Rotavirus vaccine?

  • Type
  • Indications
  • Schedule
  • Contraindications
A

Type: live, attenuated virus

Indications: universal vaccination of infants

Schedule:

  • 2 or 3 doses between 6-32 wks depending on which vaccine is used

Contraindications:

  • Hypersensitivity to vaccine components
  • History of intussusception.
  • Not recommended for immunodeficient children-has caused failure to thrive, dehydration and prolonged shedding in 3 children with SCIDS
45
Q

Rotavirus vaccine: An oral vaccine for diarrhea reduced hospitalizations of children with rotavirus by more than __% in some parts of the United States

A

Rotavirus vaccine: An oral vaccine for diarrhea reduced hospitalizations of children with rotavirus by more than 70% in some parts of the United States

46
Q

Impact of Pneumococcal infections: annual toll (US)

A
  • Meningitis: 3,000
  • Bacteremia: 50,000
  • Pneumonia: 500,000

- Acute otitis media: 7 million

* In developing countries, Sp is responsible for 10-20% of all deaths in children under 5!

47
Q

What age groups are most affected by invasive pneumococcal disease?

A
  • 1 yo
  • Followed by under 1 yo
  • Resurgence again in 65+
48
Q

Penumococcal vaccine (PCV):

  • Type:
  • Contents
  • Indications
  • Schedule
  • Contraindications
A

Type: conjugate vaccine (PCV)

  • Protein-polysaccharide conjugates representing 13 serotypes of S. pneumoniae

Recommended for:

  • All children under 5 yo
  • Children and adults 5-63 yo with certain medical conditions
  • Adults > 65 yo

Primary immunization schedule:

  • 4 doeses at 2, 4, and 6 months and at 12-15 months

Contraindications

  • Not generally recommended for persons 5-65 yo
49
Q

Outcomes of pneumococcal CV?

A

Percent protection against acute otitis media, pneumonia, and invasive disease; protective efficacy in infants

  • Associated with declines in antibiotic-resistant Sp and invasive disease in older persons (herd immunity)
  • Also associated with increase in infections caused by serotypes not in vaccine (serotype replacement)
50
Q

Pneumococcal vaccine (PPSV)?

  • Type
  • Indications
A

Pneumococcal Polysaccharide Vaccine (PPSV)

  • Purified polysaccharides of 23 serotypes

Indications:

  • Indicated for all persons who are > 65 yo
  • Persons 2 yrs or older who are at high risk

High risk:

  • Heart and lung disease
  • Hypo/asplenia
  • Complement deficiency
  • Cochlear implant
  • Nephrotic syndrome
  • Renal failure
  • Alcoholism
  • Chronic liver disease
  • Diabetes
  • Asthma
  • Cigarette smoking
  • Immunodeficiency
51
Q

What are the 2 different pneumococcal vaccines?

A
  • PCV: pneumococcal conjugate vaccine
  • PPSV: pneumococcal polysaccharide vaccine
52
Q

Protective efficacy of PPSV?

A

Risk of infection after vaccination with PPSV varies according to age and time

53
Q

Revaccination with PPSV should be done when?

A
  • People at highest risk of fatal disease (asplenia; immunosuppression) or rapid decline in antibody levels (nephrotic syndrome) > 5 years after dose 1 (a one-time revaccination strategy only for persons aged 19-64 years)
  • People who are at least 65 years old if they were under 65 years old when they received dose 1 and that dose was given > 5 years ago
  • Children > 3 years after dose 1 if they would be > 10 years old at revaccination
54
Q

PCV should be used in adults when?

A
  • 13 Valent PCV was recently licensed for use in adults ≥50 years old.
  • Recommended for all persons ≥65 years old, and persons 5 thru 64 years with high risk conditions
55
Q

Influenza:

  • Epidemics when
  • Epidemics where
  • Occurs frequently in…
A
  • Winter in temperate climates (year-round in tropics)
  • Frequently in travelers and explosive outbreaks reported on planes and cruise ships
56
Q

US Influenza Virus Vaccines include what?

Type?

Recommended for who?

A

Trivalent or quadrialent: Inactivated/Recombinant

  • Healthy and high risk > 6 mo
  • Intramuscular or intradermal

Live attenuated

  • Healthy 2-49 yo
  • Intranasal
57
Q

How do intradermal (ID) immunizations work?

A

Efficient delivery to dendritic cells ID immunization using a microinjection system ->

  • Superior serum Ab responses vs. IM immunization using similar doses of vaccine in the elderly
  • ID superior vs. A antigens in younger adults
58
Q

Primary immunization schedule for influenza?

A

Unvaccinated kids 6 mo- 9 yo

  • 2 doses given at least 4 wks apart

mmunization of others

- 1 dose each fall

59
Q

Contraindications for influenza vaccine?

A

For all:

  • Anaphylactic hypersensitivity to vaccine components

For IIV/RIV:

  • For egg allergy, ok to vaccinate if just hives
  • If more severe, refer to a provider with expertise in dealing with allergic reactions, or administer RIV

For LAIV:

  • Children on aspirin
  • H/O GBS; pregnancy
  • Close contact with severely immunocompromised persons
  • Egg allergy
  • High risk conditions; age 50 years.
60
Q

Influenza vaccine recommended for who?

A
  • Annual immunization recommended for all persons ≥6 months old!
  • Groups at highest risk for complications and death should be given special attention; immunization of these persons and their contacts (including HCWs) is of highest priority.

Specifics:

  • HD IIV,(≥65 years)
  • ID IIV (18-64 years)
  • RIV (18-49 years)
  • ccIIV (≥ 18 years)

Recently licensed; are considered suitable alternatives for the indicated age groups

61
Q

Influenza vaccination for travelers?

A

People who are at high risk and who were not vaccinated during the preceding fall or winter should receive the most up-to-date vaccine before travel if they plan to

  • Travel to the tropics
  • Travel with organized groups anytime
  • Travel to the Southern Hemisphere during April to September
62
Q

Use of high dose influenza vaccine for who? What type?

A

Persons > 65 yo

  • Fluzone high-dose: altenative inactivated vaccine for persons > 65
  • Persons > 65 can receive any of the standard-dose IIV preparations or Fluzone HD
63
Q

Rota, Pneumo, and Flu Summary

  • All infants should _____
  • PCV is recommended for ____
  • PPS23 is recommended for ______
  • Influenza vaccine is recommended annually for ___.

Consider vaccination with the most up-to-date vaccine for _____

  • _______ is conferred with these and other vaccines
A

Rota, Pneumo, and Flu Summary

  • All infants should be vaccinated against rotavirus, unless contraindicated
  • PCV is recommended for all infants, persons > 65, and high risk 6-64 yo
  • PPS23 is recommended for persons > 65, other high risk 6-64 yo
  • Influenza vaccine is recommended annually for all persons > 6 mo.

Consider vaccination with the most up-to-date vaccine for travelers

  • Herd immunity is conferred with these and other vaccines
64
Q

Where do hyperendemic-epidemic meningococcal infections occur?

Where are the different strains (A, B, C, W-135, X, and Y) found?

A

Certain parts of Africa (“meningitis belt”)

  • Group A: Africa
  • Groups B, C: industrialized countries
  • Groups W-135 and X: Africa
  • Group Y: US and elsewhere
65
Q

Risk factors for meningococcal disease?

A
  • Terminal complement deficiencies
  • Functional or anatomic asplenia
  • Occupational exposures to N. meningitidis in solutions that may be aerosolized
  • Travel to the ‘meningitis belt’ between December and June
  • Outbreaks/exposure to case
66
Q

What are the 3 meningococcal vaccines?

A
  • Purified PS of serogroups A, C, Y, and W-135 (MnPS)
  • Quadrivalent protein-PS conjugate vaccine (MnCV)
  • Men C and Y and Hib CV (Hib-MenCY-TT
67
Q

MnCV is recommended for who?

A
  • All children at age 11-12 years and again at 16 years
  • Catch-up for HS students and college freshmen living in dorms
  • Can also be used for infants aged 9 thru 24 months at increased risk for disease
  • Vaccination recommended for others ≥2 months old who are at increased risk.
68
Q

Hib-MenCY-TT recommended for who?

Schedule?

Limits?

A

Infants aged 6 wks - 18 mo who are at increased risk

  • 4 dose schedule
  • Does not protect against Men A or W
  • Does not obviate need for adolescent immunization
69
Q

Primary and booster immunization schedule for meningococcal vaccines (MnPS and MnCV)?

A

Primary Immunization Schedule

  • MnCV: 1-2 intramuscular doses (2-55 yrs); the preferred vaccine
  • MnPS: One subcutaneous dose (≥2 yrs); an acceptable alternative

Booster Immunization

  • May repeat at 3-5 years if risk persists;
  • MnCV is the preferred vaccine

Note: US-licensed vaccines do not protect against serotype B infections, but a vaccine is on the horizon!

70
Q

Recent outbreak of hepatitis A where?

A

Costco- frozen organic berry mix from Oregon

71
Q

Active immunization against HAV involves what? Efficacy?

A
  • Formalin inactivated cell culture-grown HAV adjuvanted with aluminum hydroxide
  • Protective efficacy 85-95% in healthy younger adults
  • Efficacy correlates with antibody to HAV (antibody persists >10 years
72
Q

Recommendations of ruse of HAV? Indications? Contraindications?

A

Recommended for:

  • All children between 1 and 2 years of age
  • For many 2-18 year old children in Texas ( 2 doses ≥ 6 months apart)

Indicated for:

  • Other persons who are at high risk for infection or complications (travelers, occupational risk, MSM, clotting factor recipients, etc.)

Contraindications:

  • Severe reaction to vaccine
  • 2-phenoxyethanol (Havrix®), or alum
73
Q

Recommendations for HAV in post-exposure prophylaxis?

A

For exposed persons between the ages of 1 and 40 years

  • Administration of a single dose within 14 days of exposure confers significant protection against symptomatic infection

Persons 40 years old should receive ISG.

74
Q

Summary of HAV infections: Good hygiene and dietary precautions

Pre-exposure prophylaxis

  • _______
  • _______

Post-exposure prophylaxis

  • _______
  • _______
A

Summary of HAV infections:

Good hygiene and dietary precautions

Pre-exposure prophylaxis

  • Inactivated HAV vaccine (active)**

- Immune serum globulin, or ISG (passive)

Post-exposure prophylaxis

- ISG for close contacts (under 1 or > 40 yo)

- Inactivated HAV vaccine (12 mo-40 yo)

75
Q

Hepatitis B vaccine characteristics?

  • Efficacy
  • Recommended for
  • Protection lasts how long
A

Hepatitis B vaccine characteristics

  • Recombinant HBsAG (yeast-derived); adjuvanted with alum

Efficacy: correlates with serum antibody-HBs

Recommended for:

  • Certain high-risk groups (occupational and other exposures such as DM, IVDU, etc.)

Protection lasts at least 22 yrs

76
Q

HBV Vaccine was associated with what disease in 6-14 yo Taiwanese children?

A

Hepatocellular carcinoma

77
Q

Prevention and Control of HBV infections: Summary

  • Immunization with HBsAG vaccines: _______
  • Hepatitis B immune globulin (HBIG) for ______
  • Screen _____ ; vaccine and HBIG should be given to _____
  • _____ with or without ____ for treatment of _____
A

Prevention and Control of HBV infections: Summary

  • Immunization with HBsAG vaccines: infants, older children, and high-risk adults
  • Hepatitis B immune globulin (HBIG) for postexposure prophylaxis of susceptible persons
  • Screen pregnant women and others at risk; vaccine and HBIG should be given to infants of infected mothers
  • Antivirals with or without steroids for treatment of persistent infection
78
Q

What cancers are associated with HPV (human papillomavirus)?

A
  • Almost all cervical cancers (most common)
  • 90% of anal cancers
  • 65% of vaginal cancers 50% of vulvar cancers
  • 35% of penile cancers
  • 60% of cancers of the oropharynx
79
Q

Characteristics of HPV vaccines?

  • Type:
  • Mechanism:
  • 3 vaccines
A

Subunit vaccines based on viral L1 capsid protein (forms virus-like particles); adjuvanted with alum and MPL (2vHPV) or alum alone (4vHPV and 9vHPV)

  • Elicit serum-neutralizing Abs 3 vaccines:
  • Genotypes 16 & 18 (70% of cervical cancer cases); 2vHPV
  • Genotypes 6, 11, 16 &; 18 (genital warts and most cervical cancers); 4vHPV
  • Genotypes 6, 11, 16, 18, 31, 33, 45, 52, 58; 9vHPV
80
Q

HPV vaccine

  • Efficacy
  • Indications
  • Schedule
  • Contraindications
A

Efficacy:

  • 91%-100% protection against warts and/or neoplasia-cervical, vaginal, vulvar, anal

Indications:

  • Non-pregnant females who are 9-26 yo
  • Males who are 9-21 yo (4vHPV and 9vHPV)
  • MSM and immunocompromised males through 26 yrs

Schedule:

  • 3 IM doses at 0, 2, and 6 mo

Contraindications:

  • Latex allergy (2vHPV)
  • Yeast allergy- immediate hypersensitivity* (4vHPV and 9vHPV)
81
Q

New recommendations for HPV

A
  • 9vHPV, 4vHPV, or 2vHPV for routine vaccination of females 11 or 12 years* of age and females through 26 years of age who have not been vaccinated previously or who have not completed the 3-dose series.
  • 9vHPV or 4vHPV for routine vaccination of males 11 or 12 years* of age and males through 21 years of age who have not been vaccinated previously or who have not completed the 3-dose series.
  • 9vHPV or 4vHPV vaccination for men who have sex with men and immunocompromised men (including those with HIV infection) through age 26 years if not vaccinated previously.
82
Q

Population effects of HPV immunization?

A

Recent studies in the US, England and Denmark demonstrate significant reduction in the risk of acquiring genital warts among vaccinated +/- unvaccinated women since the introduction of HPV vaccine.

83
Q

Overall childhood immunization schedule?

A